3 Clinical Trials for Various Conditions
This Phase 3 study was designed to demonstrate the net benefit of sotagliflozin versus placebo in patients with Type 1 Diabetes (T1D).
As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.
The purpose of this study is to assess the safety and tolerability of MSDC-0602 and to evaluate the reduction in fasting plasma glucose in patients with Type 2 diabetes.